
Roadside drug-driving testing
Already live in the Wellington region, roadside saliva drug testing is now being rolled out nationwide, with all regions expected to be live by mid-2026.

Already live in the Wellington region, roadside saliva drug testing is now being rolled out nationwide, with all regions expected to be live by mid-2026.

A study evaluating the impact of the University of Sydney’s microsurgical skills course (MSC) on first-year ophthalmology trainees' cataract surgery performance found it accelerated early proficiency and improved patient safety.

Essilor Instruments has launched Idra X, a fully automated ocular-surface analysis platform designed to streamline dry-eye assessment in clinical practice. Built on the Italian company SBM Sistem

A Chinese study found a significant association between long-term exposure to air pollutants and increased myopia risk among school-aged children. The large-scale cross-sectional study discove

Two years after reviewing specialised gaming lenses for NZ Optics, UK-based writer Siu-Yin Shing has now co-founded her own gaming eyewear brand, XP-Pro Eyewear, with husband Ben Summers. “I loved the XP-Pro lens concept the day I first encountered it and knew it had real potential,” Shing said.

Researchers have found the Greenland shark maintains a functional and well-adapted visual system despite extreme cold, low light and frequent corneal parasitism.

US researchers found that levels of Chlamydia pneumoniae in the retina and cerebral cortex of Alzheimer’s dementia (AD) patients were elevated compared with controls. Published in Nature Communications, the study was led by Cedars-Sinai Medical Center researchers and analysed retinal and brain tissu

A national retinopathy of prematurity (ROP) screening programme and world-first ROP image-sharing repository is now up and running in Aotearoa to improve eye-health care for premature pēpi.

Dry eye disease (DED) specialist Dr Colin Parsloe, clinical advisor to the New Zealand Dry Eye Association, is bringing advanced management of complex dry eye to the Bay of Plenty and Tauranga Eye Specialists’ Papamoa clinic.

New Zealand healthcare professionals are being encouraged to report any suspected acute, persistent vision loss associated with glucagon-like peptide-1 (GLP-1) receptor agonists, such as dulaglutide, liraglutide, semaglutide and tirzepatide.

A long-standing partnership with the South Auckland Pasifika Parkinson’s Support Group is helping University of Auckland neuroscientists probe tear fluid for biomarkers that could signal Parkinson’s disease years before clinical motor symptoms appear.

People with atopic eczema have an increased risk of developing serious eye disease, including keratoconus (KC), according to a large population-based analysis of UK health records.